WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

Lilly said in an open letter that it was "deeply concerned" about growing online sales and social media posts involving phony or compounded versions of tirzepatide, the active ingredient behind its drugs Mounjaro and Zepbound.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/l2VF4IH
via